Are peptides legal in the UK?

Two sets of law can apply to a peptide in the UK. The Medicines and Healthcare products Regulatory Agency (MHRA) enforces the Human Medicines Regulations 2012, which govern anything that counts as a medicinal product^[1]. The Home Office runs the Misuse of Drugs Act 1971 and the Misuse of Drugs Regulations 2001, which cover controlled drugs^[4]. Most research peptides fall under the first set only. A small number of peptide hormones fall under both.

Neither body keeps a list of "research peptides". The questions that matter are whether a product counts as a medicine, and whether it is named as a controlled drug. The rest of this page takes each in turn. For what research peptides are and how the market works, see what are research peptides.

The Human Medicines Regulations define a medicinal product in two ways^[1]. The first is presentation: a product presented as having properties of preventing or treating disease. The second is function: a substance that may be used by or administered to people to restore, correct or modify a physiological function. A product only has to meet one of the two.

Most peptides sold online are marketed with descriptions of what they do in the body, and many are the same molecules studied as drug candidates. The MHRA's guidance on borderline products says it decides whether something is a medicine case by case, taking account of all the characteristics of the product^[2]. That means the label is one factor, but not the only one. How a product is described, what it is, how it is packaged and how it is promoted all count.

A handful of peptides are licensed medicines in the UK in specific branded forms. The MHRA lists semaglutide (Wegovy, Ozempic, Rybelsus), tirzepatide (Mounjaro) and liraglutide as licensed GLP-1 medicines, available on prescription^[13]. The same guidance says selling them through unregulated channels is against the law, and that powder vials for mixing are not authorised^[13]. See our pages on semaglutide and tirzepatide for the research behind them.

Regulation 46 of the Human Medicines Regulations says a person may not sell or supply an unauthorised medicinal product^[3]. If a peptide counts as a medicine and has no UK licence, selling it for human use is an offence under that regulation. Selling licensed medicines outside a pharmacy or prescription is also against the law, as the MHRA points out in its GLP-1 guidance^[13].

The MHRA has acted on this. In October 2025 it described retatrutide as a medicine in clinical development that has not been approved for UK use, and said products sold outside clinical trials are likely to be illegal^[10]. In February 2026 it disrupted a facility suspected of making retatrutide and tirzepatide as well as other peptide products^[11]. In May 2026 it seized about 12,000 doses in its largest seizure of unlicensed weight-loss medicines, and two people were arrested on suspicion of offences under the Human Medicines Regulations^[12].

These cases were about manufacture and supply, not individual buyers. They do show the MHRA treats unlicensed peptide products, including retatrutide, as medicines within its remit. Read more on retatrutide.

Almost every peptide sold online in the UK carries a "research use only" or "not for human consumption" label. Many supplier websites claim this wording keeps a product outside medicines law. We could not find any MHRA statement that supports that claim, and none that addresses these labels directly either way.

What the MHRA has published is its general test: whether something is a medicine depends on all the characteristics of the product, considered case by case^[2]. A label is one characteristic. How the product is described and sold is another. Regulators in the US, Canada, Australia and New Zealand have said in writing that research-use labels do not make sales legal. The UK has no equivalent statement that we could find, so we do not say either way what a UK court would decide.

For buyers, a research-use label is also a warning sign about the product itself. It means no one has taken responsibility for the vial as a medicine, and nothing guarantees what it contains. That is why testing matters; see third-party peptide testing.

A few peptide hormones are controlled drugs in the UK. Part III of Schedule 2 to the Misuse of Drugs Act lists chorionic gonadotrophin (HCG), non-human chorionic gonadotrophin, somatotropin, somatrem and somatropin as Class C drugs, alongside clenbuterol^[4]. Somatropin and somatotropin are forms of human growth hormone. The same substances sit in Schedule 4 Part II of the Misuse of Drugs Regulations^[5].

There is no general entry for peptide hormones or growth hormone secretagogues. BPC-157, TB-500, the GHRP peptides, CJC-1295, ipamorelin and the other common research peptides are not named in either schedule^[4][5].

For the Schedule 4 Part II drugs, possession on its own is exempt from the possession offence^[6]. Supplying them is still a Class C offence. Importing them is exempt only when it is done in person, for use by that person^[6]. The Home Office says medicines containing controlled drugs cannot be posted to you from overseas^[7]. In practice that means ordering growth hormone or HCG by post from abroad falls outside the exemption.

For medicines that are not controlled drugs, the Human Medicines Regulations include a personal-use exception. The licensing requirement for imports does not apply to someone importing a medicine for administration to themselves or a member of their household^[8]. That exception is about import licensing. It does not make it legal for someone else to sell the product to you, and it does not cover buying for other people.

Quantities matter. The MHRA has said that imports seized by Border Force above reasonable personal quantities have been destroyed^[9]. Neither the regulations nor the MHRA gives a fixed number of vials that counts as personal use. Controlled drugs such as growth hormone and HCG follow the stricter rules in the section above^[7].

For growth hormone and HCG, possession is covered by the exemption described above^[6]. For other peptides, the offences in the Human Medicines Regulations that we reviewed deal with sale, supply, manufacture and import. We have not found an authority that states clearly whether simply possessing an unlicensed peptide is an offence, and we do not give an answer on it. If this matters to you, take legal advice.

Two other points apply whatever the legal position. First, no unlicensed peptide has been assessed for safety, quality or dosing by the MHRA, so nothing guarantees what a vial contains. Second, doctors, pharmacists and other regulated professionals have their own professional rules on prescribing and supplying unlicensed products, which are outside the scope of this page.

If you compete in a sport covered by UK Anti-Doping (UKAD), the World Anti-Doping Agency's Prohibited List applies. UKAD says peptide hormones are prohibited at all times, in and out of competition^[14]. The 2026 List names BPC-157 under S0, non-approved substances^[15][16]. It also names TB-500 and thymosin beta-4, the GHRH analogues CJC-1295, sermorelin and tesamorelin, ipamorelin, and the GH-releasing peptides GHRP-1 to GHRP-6 and hexarelin^[15]. Growth hormone and its fragments, including AOD-9604, are prohibited, and HCG is prohibited in men^[15].

Anti-doping rules apply regardless of whether a product is legal to buy. A "research use only" label is no defence to a positive test.

This page summarises primary sources read on the date shown. It is general information, not legal advice, and the law and enforcement practice can change. Each claim links to its source, so you can check it yourself.

If you buy peptides, PepFinder's job is to help you judge suppliers on evidence: whether they publish independent test results, how reliably they deliver, and what verified buyers say. Compare UK peptide suppliers, read how to spot a fake peptide supplier, or see how we rate suppliers. A supplier's listing on PepFinder is not a statement that its products are legal.